Cell death prevention, mitogen-activated protein kinase stimulation, and increased sulfatide concentrations in Schwann cells and oligodendrocytes by prosaposin and prosaptides

被引:98
作者
Hiraiwa, M
Taylor, EM
Campana, WM
Darin, SJ
OBrien, JS
机构
[1] UNIV CALIF SAN DIEGO, SCH MED, DEPT NEUROSCI, LA JOLLA, CA 92093 USA
[2] MYELOS NEUROSCI, LA JOLLA, CA 92037 USA
关键词
saposin C; glial cells; myelin; apoptosis;
D O I
10.1073/pnas.94.9.4778
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Prosaposin, the precursor of saposins A, B, C, and D, was recently identified as a neurotrophic factor, Herein prosaposin was found to increase sulfatide concentrations in primary and transformed Schwann cells (iSC) and oligodendrocytes (differentiated CG4 cells), Of the four mature saposins, only saposin C was found to increase sulfatide concentrations in these cell types, A similar result was obtained by using peptides (prosaptides) encompassing the neurotrophic sequence located in the saposin C domain, Dose-response curves demonstrated maximal enhancement by saposin C and prosaptides at low nanomolar concentrations (5-10 nM). The increase in sulfatide concentration by a 14-mer prosaptide, TX14(A), in CG4 oligodendrocytes was about 3-fold greater than in primary Schwann cells. A mutant prosaptide with a single amino acid replacement of Asn --> Asp was inactive. Prosaptides did not induce cell proliferation of primary Schwann cells, iSC cells, or CG4 oligodendrocytes but nanomolar concentrations of prosaptides prevented cell death of iSC cells and CG4 oligodendrocytes. Immunoblot analysis demonstrated that phosphorylation of both mitogen-activated protein kinase p-42 and p-44 isoforms were enhanced 3- to 5-fold after 5 min of treatment with prosaptides at concentrations of 1-5 nM. These findings suggest that prosaposin and prosaptides bind to a receptor that initiates signal transduction to promote meylin lipid synthesis and prolong cell survival in both Schwann cells and oligodendrocytes. Prosaposin may function as a myelinotrophic factor in vivo during development and repair of myelinated nerves explaining the deficiency of myelin observed in prosaposin-deficient mice and humans.
引用
收藏
页码:4778 / 4781
页数:4
相关论文
共 19 条
[1]  
ASOULINE JG, 1989, DISSECTION TISSUE CU, P247
[2]   ISOLATION OF ACTIVATED ADULT SCHWANN-CELLS AND A SPONTANEOUSLY IMMORTAL SCHWANN-CELL CLONE [J].
BOLIN, LM ;
IISMAA, TP ;
SHOOTER, EM .
JOURNAL OF NEUROSCIENCE RESEARCH, 1992, 33 (02) :231-238
[3]   Induction of MAPK phosphorylation by prosaposin and prosaptide in PC12 cells [J].
Campana, WM ;
Hiraiwa, M ;
Addison, KC ;
OBrien, JS .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 229 (03) :706-712
[4]   RGD-CONTAINING PEPTIDES INHIBIT THE SYNTHESIS OF MYELIN-LIKE MEMBRANE BY CULTURED OLIGODENDROCYTES [J].
CARDWELL, MC ;
ROME, LH .
JOURNAL OF CELL BIOLOGY, 1988, 107 (04) :1551-1559
[5]   Targeted disruption of the mouse sphingolipid activator protein gene: A complex phenotype, including severe leukodystrophy and wide-spread storage of multiple sphingolipids [J].
Fujita, N ;
Suzuki, K ;
Vanier, MT ;
Popko, B ;
Maeda, N ;
Klein, A ;
Henseler, M ;
Sandhoff, K ;
Nakayasu, H ;
Suzuki, K .
HUMAN MOLECULAR GENETICS, 1996, 5 (06) :711-725
[6]   DIFFERENTIALLY EXPRESSED GENES AFTER PERIPHERAL-NERVE INJURY [J].
GILLEN, C ;
GLEICHMANN, M ;
SPREYER, P ;
MULLER, HW .
JOURNAL OF NEUROSCIENCE RESEARCH, 1995, 42 (02) :159-171
[7]   SPHINGOLIPID ACTIVATOR PROTEIN-DEFICIENCY IN A 16-WEEK-OLD ATYPICAL GAUCHER DISEASE PATIENT AND HIS FETAL SIBLING - BIOCHEMICAL SIGNS OF COMBINED SPHINGOLIPIDOSES [J].
HARZER, K ;
PATON, BC ;
POULOS, A ;
KUSTERMANNKUHN, B ;
ROGGENDORF, W ;
GRISAR, T ;
POPP, M .
EUROPEAN JOURNAL OF PEDIATRICS, 1989, 149 (01) :31-39
[8]   ISOLATION, CHARACTERIZATION, AND PROTEOLYSIS OF HUMAN PROSAPOSIN, THE PRECURSOR OF SAPOSINS (SPHINGOLIPID ACTIVATOR PROTEINS) [J].
HIRAIWA, M ;
OBRIEN, JS ;
KISHIMOTO, Y ;
GALDZICKA, M ;
FLUHARTY, AL ;
GINNS, EI ;
MARTIN, BM .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1993, 304 (01) :110-116
[9]  
Kotani Y, 1996, J NEUROCHEM, V66, P2197
[10]  
Kotani Y, 1996, J NEUROCHEM, V66, P2019